Hyperfine (HYPR) Stock Price, News & Analysis

Company Overview

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Key Stats

• Today's Range: $0.85 to $0.93
• 50-Day Range: $0.85 to $1.02
• 52-Week Range: $0.76 to $1.39
• Volume: 185,302 shs
• Average Volume: 100,797 shs
• Market Capitalization: $61.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.60
• Consensus Rating: Hold

Hyperfine Stock Analysis - MarketRank™

Hyperfine scored higher than 48% of companies evaluated by MarketBeat, and ranked 567th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Hyperfine has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Hyperfine has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Hyperfine are expected to grow in the coming year, from ($0.57) to ($0.53) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hyperfine is -1.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hyperfine is -1.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Hyperfine has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.74% of the float of Hyperfine has been sold short.

Short Interest Ratio / Days to Cover

Hyperfine has a short interest ratio ("days to cover") of 16.4, which indicates bearish sentiment.

Change versus previous month

Short interest in Hyperfine has recently decreased by 3.33%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hyperfine does not currently pay a dividend.

Dividend Growth

Hyperfine does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.74% of the float of Hyperfine has been sold short.

Short Interest Ratio / Days to Cover

Hyperfine has a short interest ratio ("days to cover") of 16.4, which indicates bearish sentiment.

Change versus previous month

Short interest in Hyperfine has recently decreased by 3.33%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: 0.13

News Sentiment

Hyperfine has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,380.00 in company stock.

Percentage Held by Insiders

29.42% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 15.03% of the stock of Hyperfine is held by institutions.

HYPR Stock Analysis - Frequently Asked Questions

How have HYPR shares performed this year?

Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR stock has decreased by 24.1% and is now trading at $0.8498.
View the best growth stocks for 2024 here.

How were Hyperfine's earnings last quarter?

Hyperfine, Inc. (NASDAQ:HYPR) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.14) EPS for the quarter, hitting analysts' consensus estimates of ($0.14). The firm earned $3.64 million during the quarter, compared to the consensus estimate of $3.40 million. Hyperfine had a negative net margin of 309.42% and a negative trailing twelve-month return on equity of 57.54%.

Who are Hyperfine's major shareholders?

Hyperfine's top institutional investors include Geode Capital Management LLC (0.86%). Insiders that own company stock include Hc Sponsor Llc, Jonathan M Rothberg, Alok Gupta, Neela Paykel, Thomas Teisseyre and Khan Siddiqui.
View institutional ownership trends.

How do I buy shares of Hyperfine?

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Hyperfine own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hyperfine investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Paycom Software (PAYC), Adobe (ADBE) and Jabil (JBL).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 12/18/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:HYPR
• CUSIP: N/A
• CIK: 1833769
• Web: hyperfine.io
• Phone: 866-796-6767
• Fax: N/A
• Employees: 190
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.60
• High Stock Price Target: $1.60
• Low Stock Price Target: $1.60
• Potential Upside/Downside: +70.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-44,240,000.00
• Net Margins: -309.42%
• Pretax Margin: -309.42%
• Return on Equity: -57.54%
• Return on Assets: -50.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.44
• Quick Ratio: 5.73

Sales & Book Value

• Annual Sales: $13.26 million
• Price / Sales: 5.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.17 per share
• Price / Book: 0.80

Miscellaneous

• Outstanding Shares: 72,949,000
• Free Float: 51,487,000
• Market Cap: $68.56 million
• Optionable: Optionable
• Beta: 0.86